DNA-Polylactide Modified Biosensor for Electrochemical Determination of the DNA-Drugs and Aptamer-Aflatoxin M1 Interactions.
Veronika StepanovaVladimir SmolkoVladimir GorbatchukIvan I StoikovGennady EvtugynTibor HianikPublished in: Sensors (Basel, Switzerland) (2019)
DNA sensors were assembled by consecutive deposition of thiacalix[4]arenes bearing oligolactic fragments, poly(ethylene imine), and DNA onto the glassy carbon electrode. The assembling of the layers was monitored with scanning electron microscopy, cyclic voltammetry and electrochemical impedance spectroscopy. The configuration of the thiacalix[4]arene core determined self-assembling of the polymeric species to the nano/micro particles with a size of 70-350 nm. Depending on the granulation, the coatings show the accumulation of a variety of DNA quantities, charges, and internal pore volumes. These parameters were used to optimize the DNA sensors based on these coatings. Thus, doxorubicin was determined to have limits of detection of 0.01 nM (cone configuration), 0.05 nM (partial cone configuration), and 0.10 nM (1,3-alternate configuration of the macrocycle core). Substitution of native DNA with aptamer specific to aflatoxin M1 resulted in the detection of the toxin in the range of 20 to 200 ng/L (limit of detection 5 ng/L). The aptasensor was tested in spiked milk samples and showed a recovery of 80 and 85% for 20 and 50 ng/L of the aflatoxin M1, respectively.
Keyphrases
- circulating tumor
- label free
- single molecule
- cell free
- gold nanoparticles
- photodynamic therapy
- sensitive detection
- electron microscopy
- nucleic acid
- drug delivery
- escherichia coli
- loop mediated isothermal amplification
- quantum dots
- ionic liquid
- computed tomography
- cancer therapy
- molecularly imprinted
- mass spectrometry
- drug induced